Abstract
All of these statements about pancreatic adenocarcinoma are true, except:
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended References
Capella C, Albarello L, Capelli P, et al. Carcinoma of the exocrine pancreas: the histology report. Dig Liver Dis. 2011;43 Suppl 4:S282–92.
Cascinu S, Falconi M, Valentini V, Jelic S, ESMO Guidelines Working Group. Pancreatic cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v55–8.
Cowgill SM, Muscarella P. The genetics of pancreatic cancer. Am J Surg. 2003;186(3):279–86.
Cwik G, Wallner G, Skoczylas T, Ciechanski A, Zinkiewicz K. Cancer antigens 19–9 and 125 in the differential diagnosis of pancreatic mass lesions. Arch Surg. 2006;141(10):968–73; discussion 974.
DiMagno EP, Malagelada JR, Taylor WF, Go VL. A prospective comparison of current diagnostic tests for pancreatic cancer. N Engl J Med. 1977;297(14):737–42.
Kalser MH, Barkin J, MacIntyre JM. Pancreatic cancer assessment of prognosis by clinical presentation. Cancer. 1985;56(2):397–402.
Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Annals of Surgical Oncology, 2009:16(4):836–47.
Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg. 2009;208(1):87–95.
Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: A randomized controlled trial. JAMA. 2010;304(10):1073–81.
O’Reilly EM. Pancreatic adenocarcinoma: new strategies for success. Gastrointest Cancer Res. 2009;3(2 Suppl):S11–5.
O’Reilly EM. Refinement of adjuvant therapy for pancreatic cancer. JAMA. 2010;304(10):1124–5.
Porta M, Fabregat X, Malats N, et al. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol. 2005;7(5):189–97.
Spinelli P, Schiavo M, Schicchi AA. Endoscopy in the diagnosis and staging of pancreatic cancer. Tumori. 1999;85(1 Suppl 1):S14–8.
Tamm EP, Silverman PM, Charnsangavej C, Evans DB. Diagnosis, staging, and surveillance of pancreatic cancer. AJR Am J Roentgenol. 2003;180(5):1311–23.
van Heerde MJ, Biermann K, Zondervan PE, et al. Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head. Dig Dis Sci. 2012;57(9):2458–65.
Zamboni GA, Kruskal JB, Vollmer CM, Baptista J, Callery MP, Raptopoulos VD. Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation. Radiology. 2007;245(3):770–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Levi, J.U., Casillas, J., Ruiz-Cordero, R., Garcia-Buitrago, M.T., Hosein, P. (2016). Pancreatic Ductal Adenocarcinoma (PDAC). In: Multidisciplinary Teaching Atlas of the Pancreas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46745-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-46745-9_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46744-2
Online ISBN: 978-3-662-46745-9
eBook Packages: MedicineMedicine (R0)